JRW Behavioral Health Services

Comment on “Cannabis and the Environment: What Science Tells Us and What We Still Need to Know” (Environmental Science and Technology, Mat 11, 2021) 

Sex and dependence related neuroanatomical differences in regular cannabis users ​(Translational Psychiatry, May 11, 2021)

Gabapentinoids (Gabapentin and Pregabalin) in Five European Countries(Frontiers in Psychiatry​, May 3, 2021)

The associations between prenatal cannabis use disorder and neonatal outcomes (Addiction​, May 1, 2021-Abstract only)

​Federal Register: Public Inspection: Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder (April 27, 2021)

Illinois Opioid Overdose Epidemic During the COVID-19 Pandemic (Illinois Department of Public Health, April 16, 2021)

Toxic Nightlife Relationships, Substance Abuse, and Mental Health: Is There a Link? (Frontiers in Psychiatry, April 14, 2021)

A Serious Game to Improve Emotion Regulation in Treatment-Seeking Individuals With Gambling Disorder (Frontiers in Psychology, April 14, 2021)

Buprenorphine Opioid Treatment During the COVID-19 Pandemic(JAMA Internal Medicine, April 12, 2021)

What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review ( PORTO Biomedical Journal, April 12, 2021)

​Acute cognitive effects of single-dose intravenous ketamine in major depressive and posttraumatic stress disorder(Translational Psychiatry, April 11, 2021)

If there were an effective pharmacotherapy for cocaine use disorder, what would it do?(Addiction, April 11, 2021)

Will hope triumph over experience in pharmacotherapy research on cocaine use disorder? (Addiction, April 11, 2021) Related: Pharmacotherapeutic strategies for treating cocaine use disorder—what do we have to offer? (Addiction, April 11, 2021/abstract only)

​Attitudes and beliefs about medical cannabis among social work students: Cross-national comparison(Complementary Therapies in Medicine, April 11, 2021)   

Opportunities for Research on the Treatment of Substance Use Disorders in the Context of COVID-19(JAMA Psychiatry, April 8, 2021)

Assessment of Annual Cost of Substance Use Disorder in US Hospitals(JAMA Open Network​, April 4, 2021)

Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease (JAMA Open Network, March 24, 2021)

Cognitive Development and Cannabis Use in Adolescents (Behavioral Sciences, March 23, 2021)

​Internet Claims on the Health Benefits of Cannabis Use(Journal of General Internal Medicine, March 23, 2021)

Decision-Making in Ambiguous Situations Influences OUD Patients’ Relapse Risk ​(NIDA Notes, March 10, 2021)

​Terpenes/Terpenoids in Cannabis: Are They Important?  (Medical Cannabis and Cannabinoids, March 8, 2021)

​Interventions to Address the Opioid Crisis—Modeling Predictions and Consequences of Inaction (JAMA Open Network, March 7, 2021)

Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution (Journal of Cannabis Research, March 2, 2021)

Association of Opioid Use Disorder Treatment With Alcohol-Related Acute Events (JAMA Open Network, February 24, 2021)

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder A Randomized Clinical Trial (JAMA Psychiatry, February 24, 2021)

Do Cannabis Users Reduce Their THC Dosages When Using More Potent Cannabis Products? A Review (​Frontiers in Psychiatry, February 23, 2021)

Inhibitory Control and Craving in Dual Disorders and Recurrent Substance Use (Frontiers in Psychiatry, February 11, 2021)

​Prevalence and Co-occurrence of Alcohol, Nicotine, and Other Substance Use Disorder Diagnoses Among US Transgender and Cisgender Adults (JAMA OpenNetwork, February 11, 2021)

​Nobody Wants to Be Narcan’d: A Pilot Qualitative Analysis of Drug Users’ Perspectives on Naloxone(Western Journal of Emergency Medicine, February 9, 2021)

Assessment of Prescription Opioid Medical Use and Misuse Among Parents and Their Adolescent Offspring in the US​JAMA Open Network, February 7, 2021)

​​​Impact of an unsanctioned safe consumption site on criminal activity, 2010–2019(Drug and Alcohol Dependence, February 5, 2021)

The Current Status of Psychedelics in Psychiatry(JAMA Psychiatry, February 4, 2021)

​Consciousness, Religion, and Gurus: Pitfalls of Psychedelic Medicine(ACS Pharmacology and Tranlational Science, ​February 2, 2021)

​Intelligence quotient decline following frequent or dependent cannabis use in youth: A systematic review and meta-analysis of longitudinal studies (Psychological Medicine, January 31, 2021)

​“Some People Smoke and Drink, I Run”: Addiction to Running through an Ethnographic Lens (Leisure Sciences, January 31, 2021)

Increased Likelihood of Falling in Older Cannabis Users vs. Non-Users (Brain Sciences, January 25, 2012)

Metonitazene Begins Proliferation as Newest Synthetic Opioid Among Latest Cycle of Non-Fentanyl Related Drugs(NPS Discovery, January 25, 2021)

Opioid use as a potential risk factor for pancreatic cancer in the United States: An analysis of state and national level databases (PLOS ONE​, January 25, 2021)

Methamphetamine exposures reported to United States poison control centers, 2000–2019 ​(Clinical Toxicology, January 22, 2021)

​Multiple clinical risks for cannabis users during the COVID-19 pandemic(Addiction Science and Clinical Practice, January 21, 2021)

Association of Cannabis Use With Self-harm and Mortality Risk Among Youths With Mood Disorders (JAMA Pediatrics, January 20, 2021)

How Resilience Promotes Mental Health of Patients With DSM-5 Substance Use Disorder(Frontiers in Psychiatry, January 19, 2021)

Assessing and Addressing Synthetic Cannabinoids and Cathinones in Neuropsychiatric Toxicological Emergencies (Psychiatric Times, January 17, 2021)

National Roadmap on State-Level Efforts to End the Nation’s Drug Overdose Epidemic (American Medical Association, January 16, 2021)

​Association of Heavy Drinking With Deviant Fiber Tract Development in Frontal Brain Systems in Adolescents (JAMA Psychiatry, January 13, 2021)​​

Cannabis use while trying to conceive: a prospective cohort study evaluating associations with fecundability, live birth and pregnancy loss(Human Reproduction, January 13, 2021)

​Consideration of Adolescent Pain in Responses to the Opioid Crisis (JAMA Psychiatry, January 7, 2021)

Preliminary Drug Abuse Warning Network Data Review (January 5, 2021)

Overdose deaths involving psychostimulants with abuse potential, excluding cocaine: State-level differences and the role of opioids(Drug and Alcohol Dependence​, January 1, 2021)

Cannabis Use, Cannabis Use Disorder, and Comorbid Psychiatric Illness: A Narrative Review(Journal of Clinical Medicine, December 28, 2020)

Medical management of eating disorders: an update(Current Opinion in Psychiatry, December 27, 2020)

Monitoring the Future Study: Trends in Prevalence of Various Drugs (December 26, 2020)

Canadian Cannabis Survey 2020: Summary(December 22, 2020)

The Importance of Studying Sex and Gender Differences in Opioid Misuse (JAMA Network Open​, December 20, 2020)

Rate of Second Primary Head and Neck Cancer With Cannabis Use(Cureus​, December 18, 2020)

Post-Legalization Changes in Marijuana Use in a Sample of Young California Adults(Abstract and summary, Addictive Behavior, December 18, 2020)

Increase in Fatal Drug Overdoses Across the United States Driven by Synthetic Opioids Before and During the COVID-19 Pandemic (CDC Health Advisory, December 18, 2020)

Association Between Benzodiazepine Use With or Without Opioid Use and All-Cause Mortality in the United States, 1999-2015  (JAMA Psychiatry, December 10, 2020)

​A study of the effectiveness of naltrexone in preventing recurrence of methadone poisoning in opioid-naive children(Physician's Weekly​, December 10, 2020)

Psychedelics in Psychiatry—Keeping the Renaissance From Going Off the Rails (JAMA Psychiatry, December 9, 2020)

A Systematic Review of Interventions to Improve Mental Health and Substance Use Outcomes for Individuals with Prenatal Alcohol Exposure and Fetal Alcohol Spectrum Disorder

(​Alcoholism: Clinical and Experimental Research, December 8, 2020)

​Adverse childhood experiences are associated with at-risk drinking, cannabis and illicit drug use in females but not males: an Emergency Department study(American Journal of Drug and Alcohol Abuse​, December 8, 2020)

​An Inside Look at Depression Treatment Among Patients With Addictive Disorders(Psychiatric Times, December 4, 2020)

​Increase of Emergency Department Admittance Due to Amphetamine-Type Stimulant Overdoses in the United States (Psychiatric Advisor, November

17, 2020)

Effects of psilocybin-assisted therapy on major depressive disorder: A randomized clinical trial (JAMA, November 6, 2020)

Does cannabis alleviate tinnitus? A review of the current literature(Investigative Otolaryngology, November 5, 2020)

Is the Long-Term Use of Benzodiazepines Associated With Worse Cognition Performance in Highly Educated Older Adults? (Frontiers in Psychiatry, November 4, 2020)

Depression, Environmental Reward, Coping Motives and Alcohol Consumption During the COVID-19 Pandemic (Frontiers in Psychiatry, November 4, 2020)

​Childhood Trauma, Emotion Regulation, and Pain in Individuals With Alcohol Use Disorder(Frontiers in Psychiatry, November 4, 2020)

Issue brief: Reports of increases in opioid- and other drug-related overdose and other concerns during COVID pandemic (JAMA, October 26, 2020)

Redoubling efforts to help Americans quit smoking: Federal initiatives to tackle America's long-running epidemic (New England Journal of Medicine, October 22, 2020)

Continuous High Frequency Deep Brain Stimulation of the Rat Anterior Insula Attenuates the Relapse Post Withdrawal and Strengthens the Extinction of Morphine Seeking(Full-text paper from Frontiers in Psychiatry​, October 20, 2020)

Assessment of Changes in Alcohol and Marijuana Abstinence, Co-Use, and Use Disorders Among US Young Adults From 2002 to 2018(Abstract from JAMA Pediatrics, October 20, 2020)

Steep increases in fentanyl-related mortality west of the Mississippi River: Recent evidence from county and state surveillance(Full-text paper from Drug and Alcohol Dependence, October 8, 2020)

​Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties (Full-text paper, Journal of Translational Medicine, October 2, 2020)

Unidentified Dangerous Substance Distributed in “Trashcan” Containers Tied to ED Patients with Combative Behavior In Maryland (October 1, 2020)

Cannabis Legalization and Acute Harm From High Potency Cannabis Products: A Narrative Review and Recommendations for Public Health (Frontiers in Psychiatry, September 29, 2020) 

​Commentary: Effect of Low-Frequency Repetitive Transcranial Magnetic Stimulation on Impulse Inhibition Methamphetamine in Abstinent Methamphetamine Patients (Frontiers in Psychiatry, September 29, 2020)

American Academy of Neurology position paper on the use of medical marijuana for neurologic disorders (September 29, 2020)

​Phenibut Addiction in a Patient with Substance Use Disorder(Cureus, September 25, 2020)

​Notes from the Field: Phenibut Exposures Reported to Poison Centers — United States, 2009–2019(CDC Report, September 25, 2020)

Medical Marijuana, Recreational Cannabis, and Cardiovascular Health(A Scientific Statement From the American Heart Association, September 24, 2020)

AMA Issue brief: Reports of increases in opioid-related overdose and other concerns during COVID pandemic (September 24, 2020)

The Opioid Epidemic During the COVID-19 Pandemic(Editorial, JAMA, September 18, 2020)

Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health(September 18, 2020)

​COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States(Full-text report from ​Nature Molecular Psychiatry, September 18, 2020)

National Forensic Laboratory Information System 2019 Annual Report (September 17, 2020)

Cannabinoids for the Treatment of Opioid Use Disorder: Where is the Evidence?  (Journal of Addiction Medicine [abstract only] September 14, 2020) 

Mid-year Chicago opioid update (Chicago Department of Public Health, September 14, 2020)

E-cigarette Use Among Middle and High School Students — United States, 2020(CDC Report, September 11, 2020)

COVID-19, Medication-Assisted Treatment, and Increased Risk for Further Respiratory Depression(American Journal of Psychiatry, September 3, 2020)

Balancing the Public Health Costs of Psychosis vs Mass Incarceration With the Legalization of Cannabis(JAMA Network, September 3, 2020)

Opportunities for Research on the Treatment of Substance Use Disorders in the Context of COVID-19  (Full text article, JAMA Psychiatry, September 2, 2020)

Psychological factors associated with substance use initiation during the COVID-19 pandemic(Full text paper in Psychiatry Research, August 28, 2020)

Association of Depression With Past-Month Cannabis Use Among US Adults Aged 20 to 59 Years, 2005 to 2016(JAMA Open Network, August 20,2020)

Gender Differences in Sleep Problems Among Drug Users(Frontiers in Psychiatry​, August 19, 2020)

Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic — United States, June 24–30, 2020(CDC, August 14, 2020)

Short and Long-Term Effects of Cannabis on Symptoms of Post-Traumatic Stress Disorder(Journal of Affective Disorders, August 13, 2020)

Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease(JAMA Network Open​, August 13, 2020)

Women and alcohol  (Alcohol Research Current Reviews, August 13, 2020)

Direct Marketing Experiences Among Individuals With Current and Lifetime Gambling Disorder (Frontiers in Psychology​, August 12, 2020)

Primary Care–Based Interventions to Prevent Illicit Drug Use in Children, Adolescents, and Young Adults(US Preventive Services Task Force Recommendation Statement, August 10, 2020)

Highlights from 2020 National Drug Early Warning System "Sentinel Community Site" Reports (August 10, 2020)

​Critical Illness Secondary to Synthetic Cannabinoid Ingestion (JAMA Open Network, August 8, 2020)

Association of Maternal Opioid Use in Pregnancy With Adverse Perinatal Outcomes in Ontario, Canada, From 2012 to 2018 (JAMA Open Network, August 8, 2020)

Association of State Policies Allowing Medical Cannabis for Opioid Use Disorder With Dispensary Marketing for This Indication (JAMA Open Network, August 9, 2020)

​A Comparison of the Alpha-2-Adrenergic Receptor Agonists for Managing Opioid Withdrawal (Practical Pain Management​, August 3, 2020)

​An evaluation of food addiction as a distinct psychiatric disorder (International Journal of Eating Disorders, August 1, 2020)

​Video directly observed therapy intervention using a mobile health application among opioid use disorder patients receiving office-based buprenorphine treatment: protocol for a pilot randomized controlled trial (Addiction Science and Clinical Practice​, August 1, 2020)

What constitutes “behavioral health”? Perceptions of substance-related problems and their treatment in primary care(Addiction Science and Clinical Practice July 30, 2020)

Treating Eating: A Dynamical Systems Model of Eating Disorders (Frontiers in Psychology, July 30, 2020)

Study protocol for a group-based motivational interviewing brief intervention to reduce substance use and sexual risk behavior among young adults experiencing homelessness(Addiction Science and Clinical Practice, July 29, 2020)

Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research Guidance for Industry (FDA July 22, 2020)

Psychedelic Research and the Need for Transparency: Polishing Alice’s Looking Glass(Frontiers in Psychology, July 21, 2020)

Prolonged Remission of Major

Neuropsychophysiological Measures of Alcohol Dependence: Can We Use EEG in the Clinical Assessment of AUD?(Frontiers in Psychiatry, July 21, 2020)

Depressive Disorder After Single Nitrous Oxide Inhalation Treatment  (Frontiers in Psychiatry, July 21, 2020)

Exploring perspectives on chronic obstructive pulmonary disease in people who smoke heroin: a qualitative study (Royal College General Practitioners, July 17, 2020)

2019 Provisional Drug Overdose Death Counts(CDC, July 16, 2020) 

​Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone(Full-text paper from Addiction Science and Clinical Practice​, July 12, 2020)

Chronic Use of Synthetic Cannabinoids Is Associated With Impairment in Working Memory and Mental Flexibility (Full-text paper from Frontiers in Psychiatry, July 7, 2020)

Peripheral Endogenous Cannabinoid Levels Are Increased in Schizophrenia Patients Evaluated in a Psychiatric Emergency Setting(Full-text paper from Frontiers in Psychiatry, July 7, 2020)

The Effects of Recreational Cannabis Access on the Labor Market: Evidence from Colorado(July 6, 2020)

​The Effectiveness of Cannabis Flower for Immediate Relief from Symptoms of Depression (Full-text paper from the Yale Journal of Biological Medicine, July 5, 2020)

4F-MDMB-BICA, a novel synthetic cannabinoid(July 1, 2020)

Association of Low to Moderate Alcohol Drinking With Cognitive Functions From Middle to Older Age Among US Adults (JAMA Open Network, June 30, 2020)

​The Impact of Cannabidiol on Psychiatric and Medical Conditions(Full-text paper from Journal of Clinical Medical Research, June 29, 2020)

​HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics (From September 2019)

​State approaches to tackling the opioid crisis through the health care system(Brookings Institute June 23, 2020)

​Short and Long-Term Effects of Cannabis on Symptoms of Post-Traumatic Stress Disorder (Abstract in Journal of Affective Disorders June 23, 2020)

​A Structural Competency Curriculum for Primary Care Providers to Address the Opioid Use Disorder, HIV, and Hepatitis C Syndemic (Frontiers in Public Health, June 23, 2020)

Preventing opioid misuse and addiction: New thinking and the latest evidence(Brookings Institute June 22, 2020)

Association of Recreational Cannabis Laws in Colorado and Washington State With Changes in Traffic Fatalities, 2005-2017(Free full-text paper from JAMA Internal Medicine, June 22, 2020)

​Attenuated reward activations associated with cannabis use in anxious/depressed individuals (Full-text paper in Transitional Psychiatry, June 21, 2020)

​Counselling adolescents and parents about cannabis: A primer for health professionals (Full-text paper in Pediatrics and Child Health, June 21, 2020)

​Cannabis vaping: Understanding the health risks of a rapidly emerging trend (Full-text paper in Pediatrics and Child Health, June 21, 2020)

​Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders: A Systematic Review and Meta-analysis(JAMA Open Network full-text paper, June 19, 2020)

​Haga clic aquí para la versión en Español

Status of State Marijuana Legalization June 2020(June 19, 2020)

​​​Long-term Depression in the Nucleus Accumbens: A Neural Correlate of Behavioral Sensitization to Cocaine(Nature Neuroscience abstract, June 18, 2020)

Association of the US Outbreak of  Vaping-Associated Lung Injury With Perceived Harm of e-Cigarettes Compared With Cigarettes(JAMA Open Network, June 18, 2020)

Treatment of Stimulant Use Disorders (New from SAMHSA June 17, 2020)

Heroin Adulterated with the Novel Synthetic Cannabinoid, 5F-MDMB-PINACA: A Case Series (Full-text paper in Clinical Practice Cases in Emergency Medicine, June 16, 2020)

Associations of Maternal Prenatal Drug Abuse With Measures of Newborn Brain Structure, Tissue Organization, and Metabolite Concentrations

(JAMA Pediatrics full text paper, June 16, 2020)

Associations of Benzodiazepines, Z-Drugs, and Other Anxiolytics With Subsequent Dementia in Patients With Affective Disorders: A Nationwide Cohort and Nested Case-Control Study 

(Abstract in American Journal of Psychiatry, June 15, 2020)

​Read the editorial here

Read a commentary here

​Screening for Unhealthy Drug Use Neither an Unreasonable Idea Nor an Evidence-Based Practice  (Journal of the American Medical Association article abstract, June 12, 2020)

The Rise and Fall of the Cocaine High/ El Alza y la Baja de la Euforia Causada por la Cocaína (June 11, 2020)

Electrochemical Oxidation of Δ9 -Tetrahydrocannabinol: A Simple Strategy for Marijuana Detection(May 20, 2020)

COVID-19 in Correctional and Detention Facilities — United States, February–April 2020 (CDC Report, May 15, 2020)

Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids: A Systematic Review and Meta-analysis
​(Full-text paper in JAMA Network Open, May 1, 2020)

2020 Q1 Synthetic Cannabinoids Report (DEA, April 5, 2020)

Stigma and the Toll of Addiction (New England Journal of Medicine, April 2, 2020)

​​​Trends in Alcohol-Induced Deaths in the United States, 2000-2016 (JAMA open network, March 24, 2020)

Drug and Opioid-Involved Overdose Deaths — United States, 2017–2018
​(CDC Report, March 20, 2020)

​Complementary horse-assisted therapy for substance use disorders: a randomized controlled trial (Full-text article from Addiction Science and Clinical Practice, February 4, 2020)

Δ9-tetrahydrocannabinol exposure during rat pregnancy leads to symmetrical fetal growth restriction and labyrinth-specific vascular defects in the placenta (Full-text paper, Nature​, January 19, 2020)

Trends in Total Binge Drinks per Adult Who Reported Binge Drinking — United States, 2011–2017 (CDC Report, January 17, 2020)

The Prevalence of Methamphetamine Use is Increasing Among Individuals Entering Medication-Assisted Treatment Programs for Opioid Use Disorders  (January 8, 2020)

Marijuana: Legalization (National Council of State Legislatures, December 27, 2019)

Driving Under the Influence of Marijuana and Illicit Drugs Among Persons Aged ≥16 Years — United States, 2018 (CDC report, December 19, 2019)

Trends in Reported Marijuana Vaping Among US Adolescents, 2017-2019 (JAMA full-text letter, December 19, 2019)